UCLA researchers have developed a 3D-printed zinc-ion hybrid battery that stores 7 times more charge for cheaper grid energy ...

Self-discharge is a normally occurring phenomenon in lithium-ion battery cells. A normal cell may have a self-discharge rate of 1% state of charge (SOC) per month. The normal self-discharge rate is ...

Please provide your email address to receive an email when new articles are posted on . Higher scores on multiple plant-based diet indices were tied to less weight gain in menopause. Those in the ...

Rumors about the astonishing weight loss potential of Eli Lilly's triple hormone drug retatrutide have been circulating for months. The results of its Phase 3 clinical trial, just released by the ...

Abstract: Animal laboratory experiments have important role in the development of specialist science related to health, biology, and pharmacy. To carry out the trial of medicines, the researchers ...

WeightWatchers' Core+ program offers personalized weight loss support starting at $20 per month. The program focuses on nutrition, habit-building and community support. Core+ features specialized ...

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two years after treatment, surgery patients lost about 58 pounds on average, ...

Even after weight loss, CD4 T cells may retain an obesity-linked inflammatory memory, revealing why immune recovery may lag behind metabolic improvement. Study: DNA methylation-mediated memory of ...

For months, readers emailed Snopes and searched our website asking whether well-known public figures were really endorsing a gelatin — often specifically "pink gelatin" — trick for weight loss. The ...

Chocolate bars made from lab-grown ingredients, rather than cocoa sourced from plantations, are no longer confined to science fiction. They are now a reality, with nearly a dozen such chocolate bars ...

Weight-based pembrolizumab dosing demonstrated comparable effectiveness and safety to fixed dosing in patients with advanced non-small cell lung cancer (NSCLC). In a real-world cohort of 414 patients, ...

We conducted a retrospective cohort study of 414 patients with advanced NSCLC treated with pembrolizumab at a single center between 2016 and 2021. Patients received either fixed-dose or weight-based ...